Lithium was withdrawn at 5 weeks' gestation, and her olanzapine dosage was increased to 5.0 mg/day at 24 weeks due to hypomanic symptoms. At 25 weeks, an oral glucose tolerance test identified hyperglycaemia at 1 and 2 hours postingestion (182 and 162 mg/dL, respectively), and she was ...
欧盟HMA上市药品数据库提供OLANZAPINE NYZOL 2,5 mg药品的基本信息,包括通用名olanzapine,中文名奥氮平,ATC代码N05AH03 olanzapine以及上市许可持有人Laboratorios Lesvi, S.L. Avda. Barcelona, 69, 08970, Sant Joan Despí (Barcelona) Spain等信息的查询.
欧盟HMA上市药品数据库提供Olasyn 2,5 mg药品的基本信息,包括通用名olanzapine benzoate,中文名奥氮平,ATC代码N05AH03 olanzapine以及上市许可持有人Synthon BV The Netherlands等信息的查询.
doi:10.1016/0920-9964(96)85440-5G.D. Tollefson and C.M. Beasley and P.V. Tran and R.N. Tamura and T.M. Sanger and A. Wood and J.N. BeuzenSchizophrenia ResearchWilliamson DJ, Beasley CM, Tran PV et a1 (1996) Olanzapine versus haloperidol results of the multicenter international ...
This trial compared the efficacy and safety of a single dose range of olanzapine, 5-20 mg/day, to a single dose range of haloperidol, 5-20 mg/day, in the treatment of 1996 in- and out-patients with a DSM-III-R diagnosis of schizophrenia, schizophreni-form disorder, or schizo...
with either olanzapine (1mg/kg), betahistine (2.7 mg/kg), olanzapine plus betahistine (O+B), or vehicle (control) for 2 weeks. Quantitative autoradiography was used to detect the density of [(3)H]ketanserin, [(3)H]paroxetine and [(3)H]raclopride binding site to 5-HT2AR, 5-HTT ...
The t1/2 was 4.91 hours while k (reaction rate constant) was 0.1411h. These methods were based on extension region of the degradation product. All the proposed methods were validated and successfully applied for determination of OLZ in Olanza 5 mg tablets. The obtained results were ...
A repeat challenge with olanzapine 2.5 mg/day led to a recurrence of oedema within 5 days; her oedema was successfully treated with furosemide again. Due to the unsucces ...doi:10.2165/00128415-200611170-00050Springer International PublishingReactions Weekly...
Administration of olanzapine (1, 2.5, 5 mg/kg, i.p.) reduced oth the acquisition and expression of morphine-induced CPP in male and female mice. However, olanzapine (5 g/kg, i.p.) caused more than 80% mortality in female but not male mice. The effects of olanzapine were reversed y...
Purpose. The aim of this study was to investigate the efficacy and safety of prophylactic administration of 5 mg olanzapine (012) combined with neurokinin 1 receptor antagonist (NK1RA), 5-hydroxytryptamine type-3 receptor antagonist (5-HT3RA), and dexamethasone (DEX) to prevent nausea and ...